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Vocation: A Call to Action
“Vocation is from the Latin vocare, to call, and means the work a person is called to
by God.” – Frederick Buechner
Have you ever been awoken by the soft voice of a child who knows they ought
to be sleeping, but are kept awake by the nightmares that ensnare their minds to the
point they envision monsters hiding in every shadow? Did you happen to notice the
helplessness in their eyes, the fear in their trembling voice, and did you not try to do
everything in your power to ensure that they were safe, to get them to realize that the
visions in their head are not real and as soon as they open their eyes the demons
simply disappear. Now I ask, what would you do if you saw that same look in the
eyes of a catatonic twenty-something young woman who just happened to catch a
glimpse of a man, whose profile is vaguely similar to another’s who is serving fifteen
years in prison?
For her the demons are monsters from her past, whose actions have seared
themselves into her memory grossly invading her present without so much as a
warning. How are we supposed to help someone like her? Simply telling her that it is
over is not enough for she has heard that repeated over and over like a song stuck on
loop and it is short of impossible to try and console someone who recoils at the
slightest touch. The worst about all of this is that I cannot say she is the exception to
the rule, that this is a unique experience within our society. All one has to do is look
around, at the homeless begging on street corners, to the solders in their war torn
uniforms, to those how have seen their livelihoods swept away by forces of nature;
because if you look closely enough you may be able to see the despair in the eyes of
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those who suffer from what is commonly known as post-traumatic stress disorder
(PTSD).
Sadly, I happen to know an unfortunately high amount of people to suffer
from PTSD. I know what it is like to help someone find their second set of earmuffs
so they do not have to re-experience war during 4th of July celebrations, to talk
someone back into the present, and honestly I was proud of myself because I believed
that I was helping them to the best of my ability. However, entering into my senior
year I felt a nagging in the back of a mind that was telling me that, maybe I could do a
little bit more.
It all finally clicked for me when a friend happened to mention the
astonishingly high amount of veterans with PTSD who are living homeless in our
nation’s major cities. Sure, I have seen these men and women panhandling on the
street and tossed them extra change if I could but I never gave a second thought to the
ordeals that they are going through, and I am someone who has seen first-hand how
debilitating PTSD to someone’s livelihood. Furthermore, at least the people in my life
have the support of their family and friends but these people are out fighting this
disorder on their own with minimal resources. So I decided to join those whose
research has been done in order to serve, not only veterans, but all people who suffer
from PTSD. No longer shall I stand idle.

7

Abstract
The neurological pathways for posttraumatic stress disorder have come under
scrutiny in recent years due to emerging research on the endocannabinoid system.
Suggested involvement in the fear and stress pathways involve the pre-synaptic
modulation of corticosteroid activity upon the consolidation and extinction of
emotional memories in the hippocampus or the basolateral amygdala or possibly the
GABA, 5-HT, and NE neuronal projections that are centered in the medial pre-frontal
cortex that have been implicated in the hyperarousal and negative affect of PTSD.
This study will focus on the use of anandamide, a CB1 and CB2 agonist in the
treatment of PTSD behavioral symptoms of a rat model, specifically general anxiety,
avoidance, generalization, and spatial learning and memory. It will also utilize
immunohistochemistry to observe the neurochemical alterations that are facilitated by
the onset of the disorder and subsequent treatment in regards to the cannabinoid
receptor availability in the CA1 area of the hippocampus and basolateral amygdala.
Rats were subjected to moderate unescapable foot shocks, paired with a predatory
stressor and a novel stimulus, in conjunction with situational reminders in order to
elicit and maintain PTSD symptomology. Anandamide was shown to significantly
increase spatial memory functioning and moderately reduce avoidance behaviors, but
did not have a significant effect on anxiety or generalization behaviors.
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Introduction
Posttraumatic stress disorder (PTSD) is no longer the enigmatic disorder that
had puzzled physicians of years past. It is no longer a diagnosis that is given under
different names, such as Gulf War Syndrome, shell shock, or post-combat fatigue, but
a single diagnosis that will be given to nearly a tenth of the general U.S. population
and nearly a third of those who serve in the Armed Forces. However, while now that
it is possible to recognize the disorder focus must be shifted towards the discovery of
an underlying cause and possible treatments.
The criterion for a PTSD diagnosis been outlined in the latest iteration of the
Diagnostic and Statistics Manual (American Psychiatric Association, 2013), which
separates them into five distinct categories. The first is that one must experience a
trauma, either directly or through a close relation, which can range from combat
experience to natural disasters to sexual assaults. While this criterion might seem
obvious two meta-studies found that PTSD was found to be comorbid on average
76% of the time with borderline personality disorder in women or dependent
personality disorder in men, 66% of whom reported that they had never experienced a
trauma (Ford et al., 2015). The second involves symptoms of invasive memories or
thoughts which can manifest in ways ranging from vivid nightmares or uncontrolled
flashbacks. Third, the patient must show avoidant behaviors which can include social
withdrawal or simple everyday behaviors to avoid stimuli that are found to be
noxious. The next criterion is that patients with PTSD present with negative affect or
cognitions, which can be directed towards oneself or projected. Last is a state of
hyper-arousal which can be expressed through the partaking in reckless behavior,
9

restlessness, or constant anxiety. A patient must display behaviors in all four of these
categories for at least six months following exposure to the stressor to receive a
diagnosis.
The narrowing of symptoms to highly definable psychological categories is crucial
because it has led to the discovery of the underlying neurological structures and
chemicals that lend themselves to the clinical manifestation of the disorder. Through
extensive research it has been shown that the four major neurological structures that
have been correlated with PTSD and considered to be a part of the fear and stress
circuit within the brain are, the basolateral amygdala (BLA), the hippocampal nuclei
(CA1), the medial pre-frontal cortex (mPFC), and the hypothalamic-pituitary axis
(HPA) (Hauer et al., 2014; Ford et al., 2015). Furthermore, the neurotransmitters
involved are, glucocorticoids, GABA, serotonin (5-HT), and noradrenaline (NE)
(Ford et al., 2015). However, the most effective pharmacological treatments (SSRI’s)
that are based off the hypothesis that one or more of these systems are malfunctioning
have only proven to be 60% effective at alleviation of initial symptoms and only 20%
effective in assisting in full or partial clinical remission of the disorder (Neumeister et
al. 2015). This suggests that critical information about the fear circuit. Recent studies
(Ganon-Elazar & Akirav, 2013; Hauer et al., 2015; Neumeister, 2013) into how the
endocannabinoid system interacts with all of the components of the fear circuit seem
to point to endocannabinoids (eCBs) as being the previously missing, neuromodulatory, component.
To fully understand the complexity and the role of cannabinoids in the regulation of
the fear circuit one must look at the neurochemical control they exert in the four main
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structures of the circuit. This is best done by examining the effects that eCBs have on
the release of the known neurotransmitters (NT).

Glucocorticoids

Glucocorticoids (GCs) are known as the stress hormone as they are released via the
HPA axis in response to stressful stimuli. What is unique about the relationship
between eCBs and GCs as that it is bidirectional. It begins with the initial release of
GCs causing a Ca++ cascade that activates the enzymes that convert lipid membrane
into eCBs (Hillard, 2000). The eCBs then bind pre-synaptically and act as a
feedforward mechanism facilitating the release of GCs, until a point where the
buildup of both NTs causes eCBs to act as a feedback inhibitor and prevent any
further release of GCs (Ganon-Elazar & Akirav, 2013; Neumeister, 2013; Evanson et
al., 2010). Meanwhile GCs are up and down regulating the availability of eCB
receptor (CB1 and CB2) availability, specifically in the BLA and hippocampus
(Neumeister et al. 2013; Neumeister et al., 2015). Furthermore, a buildup of the GCs
precursor, corticotrophin releasing hormone (CRH), activates fatty acid amide
hydrolase (FAAH) which breaks down the eCBs in the synapse (Gray et al., 2015).
Seemingly, both NT are required to maintain proper control and normal levels of the
other (Cota et al., 2007).
While these two NTs might assist each other chemically in regards to behavior,
specifically aversive memory consolidation and extinction, they are the antithesis of
each other. Synthetically increased levels of GCs in the BLA and hippocampus have
11

been shown to facilitate the consolidation, hinder extinction, and even re-consolidate
conditioned fear responses (Campolongo et al., 2009). The injection of synthetic
cannabinoids or inhibition of FAAH on the other hand has been shown to facilitate the
extinction of aversive memories, without any psychoactive effects altering initial
consolidation or conscious recall (Campolongo et al., 2009; Chhatwal et al., 2005;
Bitencourt et al., 2013; Das et al., 2013). Interestingly, this effect is time dependent in
that the injection only facilitates extinction if given hours after the exposure to the
stressor, if given earlier it seems to have a preventative effect (de Oliveira et al.,
2008). This suggests that eCBs are effectively reducing the levels and effects of GCs.
This idea is backed by evidence that CB1 receptors in the BLA are down-regulated
and those in the hippocampus are up-regulated. These differing regulations would
lead to smaller initial but chronic GCs activation in the BLA, which is consistent with
the over activation theory of PTSD (Neumeister et al., 2013), and a short but initial
flooding of the hippocampus, which could lead to the oxidative and subsequent
atrophy seen in a majority of PTSD patients.
It is important to note that while researchers still debate whether or not a reduced
hippocampal size is evident of PTSD or if it is simply a risk factor, but they do agree
that hippocampal dysfunction is present in patients with PTSD (Neumeister et al.,
2015). This is evidenced by the poor performance of PTSD patients and animal
models of PTSD on spatial memory tasks. Therefore, it is possible that CBs could
prevent or cause this damage depending on the regulation of their receptors. Overall,
this evidence suggests that CBs could be used to facilitate the extinction of avoidance
behaviors as well as the destruction of hippocampal neurons through the regulation of
GCs in the brain.
12

GABA

Through years of research it has been shown that GABA acts as the main inhibitory
NT in the brain. Ford et al. (2015) explains that the main GABAminergic projections
in the fear and stress pathway begin in the mPFC and terminate in the BLA. They
suggest that the over-activation of the amygdala might be due to a lack of inhibitory
signals by the mPFC which can result in the lack of ability to distinguish between a
potentially dangerous or harmless stimulus (Lin et al., 2009). Lin et al. (2009) and
Ratano et al., (2014) have shown that the activation of novel CB receptors by the
synthetic cannabinoid, cannabidiol CBD, on the GABAminergic neurons could
potentially assist in the release of the NT and potentiate the inhibition of BLA
activation. This suggests that CBs could potentially reduce the amount of generalizing
behavior by reducing the amount of BLA activation.

Serotonin & Noradrenaline

While the interconnectedness of the serotonin and noradrenergic and the
cannabinoid system has not been as extensively researched as the previous systems,
recent discoveries show promising results.
The NE neurons in the mPFC are utilized to activate the bodies sympathetic nervous
system (SNS) which controls arousal states (Morilak, 2012). The injection of CBD
13

into the mPFC has shown to decrease arousal when administered after exposure to a
stressor, but increases it if given prior to exposure (Fogaça et al., 2014). This suggests
that the eCB modulation of NE could be similar to that of GCs and be used to reduce
hyperarousal-induced anxiety.
The 5-HT neurons in the mPFC are related to emotional control, expressly depressive
behaviors. Marinho et al., (2015) and Sartim et al., (2016) directly injected CBD into
the mPFC of rats, after extended periods of inescapable restraint, and found that it
reduced depressive symptoms. Furthermore, they showed that this effect could be
blocked via the co-injection of a 5-HT antagonist. This suggests that the pre-synaptic
activation of CB receptors could be utilized to reduce negative affect and related
negative cognitions.
This study attempts to determine the effectiveness of using cannabinoids as a
treatment for PTSD symptoms by targeting the areas of interaction outlined above. It
will utilize the eCB, anandamide which is the intrinsic activator of CB1 and CB2
receptors, to provide insight as to whether or not CB are a viable target for future
synthetic pharmacological interventions.
This study will induce PTSD in a rat model so that the symptoms developed will be
comparable to those laid out for humans in the DSM 5 but still adhering to reactions
that can be observed in nature for the selected animal model as presented by Ford et
al. (2015). It will also attempt to observe all changes made to all behaviors related to
PTSD in regards to the pharmacological interventions.
This study suggests that the cannabinoid system act in a neuro-modulatory fashion
within the fear and stress pathways and that it is the disruption of this system that is at
14

the center of PTSD symptomology. Furthermore, the application of cannabinoids
should restore the cannabinoid control of glucocorticoid, GABA, NE, and 5-HT
release which should reduce the clinical presentation of their related symptomologies.
My hypotheses are that (1) rat behaviors, such as anxiety, avoidance, and
generalization, will be increased, while spatial memory will decrease due to the
application of the stressors. (2) Any behavioral changes due to the trauma will be
alleviated by the application of the pharmacological intervention of anandamide. (3)
The regimented administration of the pharmacological intervention. (4) There will a
downregulation of CB1 and CB2 receptors in the hippocampus and an upregulation of
receptors in the basolateral amygdala with the application of anandamide in
comparison to the control.
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Methods
All procedures were carried out under strict compliance with ethical
principles and guidelines of the NIH Guide for the Care and Use of
Laboratory Animals. All treatment and testing procedures were approved by
the Intuitional Animal Care and Use Committee of Regis University in
Denver, Colorado.

2.1. Animals

Adult, male Charlie-River rats will be used throughout the study. The
animals were housed singly or in pairs in a cage with a width of 25 cm, a
length of 45 cm, and a height of 25cm. The conditions in the animal facility
will be stabilized at room temperature. The animals were in an environment
with a twelve-hour alternating light/dark cycle with the light being initiated
at 6:00 and dark at 18:00. All animals had food and water available ad libitum.
The cage bedding was changed every three days. All subjects were allowed to
adjust to their environment for a week before experimentation began.

2.2. Experimental design
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This study consisted of four main experiments, three of which assessed
the effectiveness of anandamide as a treatment through the observation of
differing behavioral symptoms of post-traumatic stress disorder in an animal
model. The fourth was a brain imaging study that utilized
immunohistochemistry to analyze the differentiation of cannabinoid receptor
availability in the basolateral amygdala and hippocampus between the
control and experimental groups. The independent variable is treatment
levels. The first facet being that the rats were either controls and given a saline
injection or in the experimental groups and given anandamide. The second
facet is treatment regimen, where one experimental group received a single,
initial injection and the other experimental group received weekly injections
in addition to the initial injection post stressor. The dependent variables are
the subjects’ performance on an elevated plus maze, a modified elevated plus
maze, a Morris water maze, and qualitative levels of cannabinoid receptors in
the hippocampus and amygdala.

2.3 PTSD Model Induction

Due to the increase in funding for PTSD research since the 1990’s there
has been multitudes of research protocols developed for the production of
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PTSD symptoms in animal models (Campos et al.. 2013; Corral-Frias et al.,
2013). This experiment integrated the most replicable aspects of each model in
order to constructively and consistently induce a rat model of PTSD.
PTSD was induced one and a half weeks after the subjects were
randomly assigned to either of the two experimental groups or the control
group, allowing them to acclimate to the possible stressors of being handled
in the animal facility. For the experimental application of stress, the rats were
first placed in a bright white chamber and allowed to acclimate to it for 5
minutes. This chamber served as the situational reminder, which has shown
to increase the duration of behavioral symptoms of PTSD under experimental
conditions without causing extinction of behavior through placing the rat in
the operant chamber without shocks (Korem &Akirav, 2014; Louvart et al.,
2005; Pynoos et al., 1996). The rat was then placed in a darkened standard
operant chamber and allowed to acclimate for thirty seconds. Then an
unavoidable foot shock was applied (1.5 mA intensity, 0.5 sec duration)
randomly every 30 seconds for a total of 10 minutes in combination with a
predatory stressor (Korem &Akirav, 2014). Exposure to a novel object, a
yellow soft-flight golf ball, was included during the stressing environment
and was later utilized as an aversive stimulus in the modified elevated plus
maze.
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All subjects will receive treatment of either anandamide (5mg/kg) or an
equivalent amount of 9% saline solution via i.p. injections two hours after the
initial stressor event. Additionally, one of the experimental groups received
weekly injections of anandamide (5mg/kg) starting one day following
situational reminder testing.

2.3.1 Situational Reminder

All subjects were placed back in the original bright white chamber, for
one minute, 3 and 5 days after the initial stressor which acted as a situational
reminder. The rats were not exposed to either the stress chamber or the novel
object, soft-flight golf ball, in order to prevent situational extinction of the
aversive memory (Korem &Akirav, 2014; Louvart et al., 2005; Pynoos et al.,
1996). Their activity within the chamber was observed by the experimenter
but not recorded.

2.4. Chemicals

Anandamide is one of two known neurotransmitters that is lipid in
nature and therefore cannot be directly injected or directly dissolved in saline
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solution. Therefore, the anandamide (5mg/kg) was first emulsified in DMSO
(10g/mL) and then mixed with enough 0.9% saline solution, which acted as a
vehicle, to achieve ± 5% concentrated dose which was given intraperitoneally
at a volume of 1.5mL per kg of weight. The control rats were given a similar
dose of just the vehicle, 0.9%saline solution, as it has been previously shown
that DMSO has no behavioral effects on rats in a PTSD model up to
concentrations well above 10% (cite) and it reduces the chance of accidently
using a contaminated chemical. Due to the nature of the synthesis the
anandamide was emulsified and placed in the vehicle the day of the initial
stressor and was covered and refrigerated in between injections, and allowed
to reach room temperature before being injected.

2.5. Behavioral Testing

In order to analyze the behavioral symptoms of general anxiety,
avoidance, and generalization the subjects were tested on their performance
on the elevated-plus maze and modified elevated plus maze, 7 and 28 days
and 14 and 28 days respectively, after the initial stressor event. The subjects’
spatial learning performance on the Morris Water maze was tested 10 days
following the last situational reminder trial, and a probe trial to examine

20

spatial memory was conducted 10 days following the last spatial learning
trial. All observations and recordings were made by the primary investigator.

2.5.1. Elevated Plus Maze

The Elevated Plus Maze (EPM) (Figure 1) is a common behavioral test
utilized to assess the subjects’ general anxiety levels following a stressor and
in this study subsequent situational reminders (Gobira et al., 2013). The
ideology behind the EPM is that it contrasts the subjects’ natural exploratory
behavior against its desire to protect itself and that the more anxious the
subject is, the more it will want to be protected and therefore the more time it
will spend within the closed arms of the maze. The EPM consists of four arms
with a length of 80 cm and a width of 6 cm that are suspended 60 cm off of the
ground. Two of the arms are enclosed on the sides and end, were darkened
using black construction paper, and given the designation of closed and the
others were not enclosed at all and designated as open. There was also
depressed area of the maze, 6 cm x 6 cm, in the center where all four arms
connected which was considered as a neutral space. At the beginning of
testing all subjects were placed in the neutral space facing the open arm away
from the experimenter and allowed to roam freely throughout the maze and
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the time spent in the arms is recorded. The subject was considered to be
located on an arm when all four legs had crossed the line that separated the
arm from the neutral space. The time that was spent in the neutral space,
when all four legs were within the separatory boundaries, was recorded as its
own location rather than being in either a closed or open leg. The subjects’
anxiety level was then recorded as a ratio determined by the amount of time
spent in the closed arms of the maze in relation to the total time spent in the
maze.
2.5.2. Modified Elevated Plus Maze

The Modified Elevated Plus Maze (MEPM) is identical to the EPM in
all dimensional aspects except that in the corner of one of the closed arms is
the yellow soft-flight golf ball that was presented during the stressor period
as the paired stimulus, and in the opposite arm is another soft-flight golf ball
that is similar in all aspects except that it is orange, as an unpaired stimulus
(Figure 2). The object placement This test assesses the subjects’ avoidance
behavior in regards to an aversive stimuli and to see of the stressor was
strong enough to cause the generalizability of aversive stimuli often seen in
subjects of classical conditioning. While previous studies (Kniss, 2012) utilized
ball burying behavior to assess avoidance behaviors, it has been pointed out
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that this behavior has only been intermittently observed under strictly
experimental conditions and is not believed to consist of any natural
behaviors.
The MEPM on the other hand allows for the subjects’ to physically avoid the
paired stimulus by escaping to an arm of the maze that does not contain the
object. As in the EPM, all subjects were started by being placed in the neutral
area of the maze facing the open arm opposite of the experimenter and
allowed to roam freely for 5 minutes. However, time spent in the closed arm
with the paired object was recorded separately from the time spent in the
closed arm with the unpaired object.
The subjects’ avoidance behavior will be assessed via an avoidance
ratio which will analyze the amount of time that they spend outside of the
arm that contains the paired object in regards to the total amount of time that
is spent in the maze. Furthermore, if the subjects’ attempt to avoid both the
paired object and the unpaired object then one may assume that the stressor
event lead to the generalization of the paired object, which could be
instrumental in understanding the symptomology of PTSD. The subjects’
generalization behavior will be assessed via a generalization ratio which will
analyze the amount of time spent on either the open arms or neutral space in
regards to the total time that is spent in the maze.
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2.5.3 Morris Water Maze

Ford et al. (2015) have shown that damage or alterations to the
hippocampus caused by stressing events have also been shown to affect
scores on spatial learning and memory. The Morris Water Maze (MWM) was
used to assess the subjects’ spatial learning and memory. The maze is a black
circular tub that is 165 cm in diameter and was filled to a depth of 80 cm. Yarn
was then suspended above the maze to section it into four separate quadrants
which were then arbitrarily given designations that correspond to locations
upon a compass for use of reference throughout the entirety of the experiment
(Figure 3). Novel pictures of differing shapes and colors were then placed on
specific points throughout the experimentation room so that they could
possibly be used as location references. Finally, a stand was placed in the East
quadrant so that it was submerged about 1 cm beneath the water’s surface
and concealed by making the water slightly opaque with powdered milk.
Testing began by placing the subject in a quadrant about 3cm from and facing
the wall and allowing them to freely explore the maze. The time it took the rat
to find the platform was recorded, and if they could not find it within a
minute they were gently guided to the platform and allowed to stand on it for
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ten seconds. All subjects were started in each of the four quadrants per day,
starting in the West and rotating clockwise, and were tested over four days
resulting in a total of 16 trials per rat. 10 days following the last acquisition
trial, a probe trial was run to assess the subjects’ spatial memory. Like the
learning trials the subjects were started 3cm from and facing the outer wall,
however they were only tested from the West quadrant and the platform had
been removed. The amount of time each rat had spent in the target quadrant,
which was determined by the whole body, excluding the tail, crossing the
dividing lines, was then recorded.
2.6. Immunohistochemistry
After experimentation was completed all subjects were euthanized via
i.p. injection of euthasol (150 mg/kg) and their brains allowed to fix in 9%
para-formaldehyde for 24 hours. The brains were then transferred into a 25%
sucrose solution in PBS. The brains were then placed in a cryostat and sliced
30 microns thick and then placed and allowed to freely float in 2 mls wells.
For labeling of CB receptors slices were first rinsed with 0.1 M PBS and later
in combination with 0.2% Triton-X, between which blocks for endogenous
peroxidases and non-specific blocks were applied. They were then placed into
a solution containing 2% NGS, and the primary antibodies (Millipore, 209550100Ul Anti-Cannabinoid Receptor CB1 (1-77), Lot D00175686) at a 1:1000
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dilution and then allowed to incubate overnight at 4°C. After incubation and
rinse, the slices were incubated in the secondary antibodies (Vector, BS 1000
Biotinylated Goat Anti-Rabbit, Lot C 12 03) at a dilution of 1:200. They were
then immersed in ABC solution (ABC Elite Kit, Vector, PK-6100) for
amplification and then rinsed. Finally, they were placed in DAB (DAB
Peroxidase Substrate Kit, Vector, SK-4100) until visibly stained. Once rinsed
slices were then placed on slides and allowed to dry before characterization.
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Results

All data were evaluated for skewness and kurtosis to identify whether
or not the data were normalized, which is an intrinsic assumption made by
the SPSS software. If the data were not normal box plots were used to identify
outliers for removal, after which skewness and kurtosis were ran again until
population was normalized to ensure more accurate interpretation of the
data.
3.1. Elevated Plus Maze
The elevated plus maze assessed the degree of anxiety exhibited by the
subjects’ post-stressor. The anxiety ratios were analyzed for both the effects of
treatment, treatment or no treatment and treatment regimen, and time.
Using a repeated measures generalized linear model, this study found
no main effects of treatment or time on the anxiety ratios. The mean anxiety
ratios at 7 days post-stressor were, .407 ± .322 for the control, .744 ± .116 for
the initial injection group, and .692 ± .133 for the multiple injection group
(Figure 4). The mean anxiety ratios at 28 days post-stressor were, .683 ± .421
for the control group, .690 ± .373 for the initial injection group, and .772 ± .233
for the multiple injection group (Figure 4). The main effect of time was not
significant on the anxiety ratios recorded, F(1,20) = 1.888, p= .185. The main
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effect of treatment was not significant, F(2,20) = 1.505, p=.246. There was no
significant interaction between time and treatment on anxiety, F(2,20) = 1.493,
p = .249.
3.2. Modified Elevated Plus Maze
The modified elevated plus maze assessed the avoidance and
generalization behaviors exhibited by the subjects’ post-stressor. The
avoidance and generalization ratios were analyzed for both the effects of
treatment, no treatment or treatment and treatment regimen, and time. Using
a repeated measures general linear model, this study found marginal main
effects of treatment and time on avoidance ratios, but no significant
interaction between the two.
The mean avoidance ratios at 14 days post-stressor were, .900 ± .10494
for the controls, .758 ± .180 for the initial injection group, and .752 ± .099 for
the multiple injection group (Figure 5). The mean avoidance ratios at 28 days
post-stressor were, .767 ± .309 for the control group, .728 ± .270 for the initial
injection group, and .495 ± .282 for the multiple injection group (Figure 5).
There was a marginal main effect of time on avoidance ratios, F(1,19) = 3.720,
p =.069. A post hoc Bonferroni analysis showed that avoidance ratios were
.140 lower at 28 days post-stressor than they were at 14 days. There was also a
marginal main effect of treatment on avoidance ratios, F(2,19)= 3.010, p =.073.
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There was, however, not a significant interaction between time and treatment
on avoidance ratios, F(2,19)= 1.160, p=.335.
Using a repeated measures generalized linear model this study found a
marginal main effect of time, but no main effect of treatment on generalizing
ratios. The mean generalization ratios at 14 days post-stressor were, .370 ±
.432 for controls, .415 ± .337 for the initial injection group, and .1877 ± .091 for
the multiple injection group (Figure 6). The mean generalization ratios at 28
days post-stressor were, .2134 ± .180 for controls, .308 ± .341 for the initial
injection group, and .130 ± .103 for the multiple injection group. There was a
marginal main effect of time on generalizing ratios, F(1,18) = 4.201, p=.055. A
post hoc Bonferroni analysis showed that the generalization ratios at 28 days
post stressor were .107 lower than those 14 days. There was no main effect of
treatment on generalizing ratios, F(2,22) = 1.285, p =.301. There was also no
significant effect of the interaction between treatment and time on the ratios,
F(2,18) = .254, p=.778.
3.3. Morris Water Maze
The Morris water maze consisted of two separate testing periods, the
first of which assessed the subjects’ spatial learning, and the second of which
assessed their spatial memory. Acquisition training scores were analyzed for
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effects of both time and treatment, and the probe trial was analyzed for effects
of treatment.
Using a repeated measures generalized linear model, this study found
a significant main effect of time but did not find a main effect of treatment on
spatial learning. There was a significant main effect of time on spatial
learning trials F (15,330) = 10.649, p <.001. After establishing significance, a
post-hoc Bonferroni test was applied which showed that all subjects took
significantly longer to find the platform on trial 1, 20.597 sec, then all other
tests except for trial 2, p<.010 and p=.582, respectively. It also showed that the
subjects took significantly longer times on trial 2 than on trials 8,11,15, and 16,
p<0.028. There were no significant differences between all other trials, p=1.000.
There was no main effect of treatment on acquisition training F (2,22) = 1.000,
p=.384. There was no effect of the interaction of between treatment and time
on the acquisition trials F (2,22) = 1.549, p=.257.
Using a one-way ANOVA, this study found a significant main effect of
treatment on spatial memory. The mean times that the subjects spent in the
target quadrant were, 20.48 ± 4.23 for controls, 23.51 ± 2.71 for the initial
injection groups, and 29.93 ± 7.42 for the multiple injection group (Figure 7).
There was a significant main effect of treatment on the probe trial, F(2,22) =
6.291, p=.007. A post-hoc Bonferroni test showed that the multiple injection
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group stayed in the target quadrant significantly longer than both the control,
p=.012, and initial injection groups, p=.041, 9.45sec and 3.03sec respectively.
There was not a significant difference between the control and initial injection
groups, p=.940.
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Discussion
4.1. Elevated Plus Maze
The main results of the Elevated Plus Maze suggest that the
administration of cannabinoids do not reduce the general anxiety levels of
rats who have been exposed to stressors. Furthermore, results show that time
also does not produce any significant change in anxiety levels.
While these results seem to conflict with some of the results of current
literature that show that cannabinoids should be anxiolytic the discrepancy
between them could be explained in two different ways. The first being that
the waiting period between the trauma and the initial injection was not long
enough and accidently ended up producing the anxiogenic effects that were
seen in Fogaça et al., (2014). Since none of the other behavioral tests seemed to
be affected by this reversal of expectations, it might be possible that the
cannabinoid modulation of the NE receptors in the mPFC is through a novel
mechanism and not the proposed regulation of glucocorticoids. This
undefined mechanism might be related to uncharacterized cannabinoid
receptors in the brain that have higher affinity binding for synthetic
cannabinoids like CBD which are not direct CB1 agonists.
The second explanation correlates to the structures involved in the
activation of the SNS. While studies have shown that cannabinoids have an
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anxiolytic effect, the majority of them have centered on eCB activity in the
mPFC and not ones in the locus coeruleus. It is possible that the anandamide
was not able to fully activate the GABA inhibition of the amygdala, which
would have led to an increase in arousal even if anandamide was modulating
the transmission of NE from the mPFC.
Experimentally testing these two theories would actually be quite
simple. The first experiment would consist of varying the time of the initial
injection from beginning just after the exposure to a stressor to more than 24
hrs following it. This would allow one to see if the presentation of anxiety is
dependent upon the time of injection. For the second experiment one would
have to inhibit the locus coeruleus while applying the cannabinoids and if
there is a anxiolytic effect than you could assume that it was due to activation
in the mPFC and if not you could say that it might not be the activation of
CB1 receptors that result in the modulation of anxiety, but rather some other
cannabinoid receptor.

4.2. Modified Elevated Plus Maze

The main findings of the Modified Elevated Plus Maze are that time
has marginal main effects on avoidance and generalization behavior whereas
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cannabinoids only have a marginal main effect on avoidance behaviors. This
suggests that avoidance and generalization behavior might have a cognitive
component to it that allows for the behaviors to be reduced over time.
However, it also shows that the injection of cannabinoids does facilitate in the
reduction of avoidance behavior.
The reduction in the avoidance behavior can be due to three different
mechanisms (Neumeister et al., 2015). The first is that the cannabinoids act
directly upon the BLA, reducing the levels of GC’s facilitating in the complete
extinction of the traumatic memory. Secondly, the cannabinoid could be
activating the GABAminergic neurons in the brain bolstering the suppression
of BLA activity resulting in the conscious differentiation between the stimuli.
Lastly, the cannabinoid could be acting upon the hippocampus and through
GCs control, allowing for the correct contextual information about the
traumatic event to be projected to the mPFC.
Since the injection of anandamide did not have a significant effect upon
the generalization behavior of the subjects one could assume that they are not
acting within the mPFC to facilitate conscious differentiation. However, if one
wanted to pinpoint the precise area of action they would most likely need to
utilize micro dialysis to detect which cortical area has lower levels of GCs or
through the cortical injection of synthetic cannabinoids.
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4.3. Morris Water Maze

The main findings of the Morris Water Maze are that cannabinoids
increase spatial memory as evidenced by increased time in the target
quadrant. This finding is substantial because atrophy and dysfunction in the
hippocampus is a hallmark of PTSD and if cannabinoids are able to have any
preventative measures against that, they could be considered as good
candidates for clinical use. This candidacy is bolstered by the data that shows
that cannabinoids do not effect spatial learning, a negative side effect that is
flaunted by public media and had it been proven could have dangerous
consequences (Das et al., 2013; Goodman & Packard, 2015; Varvel& Lichtman,
2002). Furthermore, since the increase in spatial memory is fairly conclusive of
eCB activity within the hippocampus, there is more evidence that the
marginal significance that was found in the MEPM related to avoidance
behavior might be due to increase contextual information being able to be
projected from the hippocampus.
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Conclusion
Overall, the data significantly or marginally supports the hypothesis
that exposure to stressors cause worsening PTSD like symptoms in animal
models, and that the systemic application of cannabinoids helps to reduce
those symptoms. It does not support the idea that any level of cannabinoid
would help in alleviating the symptoms of PTSD as in many of the tests there
was no difference between the control and initial injection groups. So, taking
it at face value the data is evidence in support of the idea that the
dysregulation of the cannabinoid system might be at the center of PTSD
symptomology, and that the administration of cannabinoids might be the
answer to providing full clinical remission to all of its sufferers.
However, interesting questions are not the ones that the data answers
but the ones they ask. While this study has shown that cannabinoids do work
at alleviating PTSD the focus should now be shifted onto how/why they
work. This study has laid the groundwork, the big picture if you will, for
going back and looking at sections of the interaction between cannabinoids
and the fear circuit piece by piece in order to more clearly define the
pathways in which cannabinoids could be used to reduce PTSD
symptomology or even lead to its prevention.
Going forward, research should include video analysis of all
behavioral testing for greater accuracy to prevent larger than desired
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confidence intervals and prevent researcher fatigue. Future research should
also add a behavioral test for depression so that negative mood and cognition
may be observed in conjunction with the other symptoms.
In conclusion, while this study barely scratched the surface of what
could be the cannabinoid theory of PTSD, it provides some evidence that
cannabinoids could be a viable candidate for clinical purposes and contributes
to the ever expending knowledge of the neuroscience and PTSD research
fields.
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Figure 1.-Aerial view of the Elevated Plus Maze. Note that the apparent
curvature is due to the construction paper and not an altered flooring
angle

38

Figure 2.– Detailed images of an example orientation and location of stimuli in the
Modified Elevated Plus Maze

39

Figure 3.– Image of the Morris Water Maze with gridlines and subject for reference
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164. There was not, however, a significant interaction between treatment and
time, F (2,19)= 1.160, p=.335.

Figure 5. This figure illustraits the mean avoidence ratios for all treatment conditions
at 14 and 28 days post-stressor. There was a marginal main effect of treatment, F
(2,19)= 3.010, p=.071, η 2 = .241. There was also a marginal main effect of of time, F
(1,19)=3.720, p=.069, η 2 = .164..
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Figure 6.- This figure illustrates the mean generalizing ratios for all treatment
condition on the Modified Elevated Plus Maze at 14 and 28 days post-stressor. This
study found a marginally significant main effect of time, F (1,18)= 4.201, p=.055.
This study found no main effect of treatment, F (1.285)= 1.285, p=.301
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Figure 7.- This figure illustrates the mean time that the subjects in each of the
treatment groups spend in the target quadrant of the Morris Water Maze during the
probe trial. This study found a significant main effect of treatment, F (2,22)= 6.291,
p=.007
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